35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity 35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity

Transforming Growth Factor Market is expected to surpass revenues worth US$ 798.2 million by 2033 - According to Persistence Market Research New York, April 19, 2023 (GLOBE NEWSWIRE) -- The Global Transforming Growth Factor Market was valued at USD 362.7 million in 2022 and is projected to reach USD 798.2 million by 2033, with a CAGR of...